The drug has emergency use authorization for high-risk groups in which it has been effective in reducing hospitalizations and deaths.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ymGUl6V
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Pfizer stops enrollment in Paxlovid trial in standard-risk population
https://ift.tt/JO103NV
No comments:
Post a Comment